Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with KEYTRUDA® (pembrolizumab)
August 19, 2021 07:00 ET
|
Adagene Inc.
SAN FRANCISCO, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and...
Adagene Announces Appointment of Interim Chief Medical Officer and New Members of Scientific and Strategic Advisory Board
August 12, 2021 07:45 ET
|
Adagene Inc.
SAN FRANCISCO, Calif. and SUZHOU, China, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene” or the “Company”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company...
Adagene Announces Clinical Trial Collaboration With Merck to Advance Two Anti-CTLA-4 Monoclonal Antibody Programs (ADG116 and ADG126) in Combination Therapy with KEYTRUDA® (pembrolizumab)
July 22, 2021 07:45 ET
|
Adagene Inc.
SAN FRANCISCO, July 22, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and...
Adagene Announces Authorization of Share Repurchase Program up to US$20 Million
July 07, 2021 07:45 ET
|
Adagene Inc.
SAN FRANCISCO and SUZHOU, China, July 07, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the...
Adagene 宣佈納入 FTSE Russell 指數
June 16, 2021 07:45 ET
|
Adagene Inc.
美國三藩市和中國蘇州, June 16, 2021 (GLOBE NEWSWIRE) -- Adagene Inc.（下稱「 Adagene」）(Nasdaq: ADAG) 是一家平台驅動的臨床階段生物製藥公司，致力改革基於抗體的新型免疫療法的發現和開發，今天宣佈將納入全球股票指數系列（「 GEIS」）中，包括富時全球全市場指數 (FTSE Global Total Cap Index)...
天演药业宣布纳入FTSE Russell指数
June 16, 2021 07:45 ET
|
Adagene Inc.
旧金山和中国苏州, June 16, 2021 (GLOBE NEWSWIRE) -- 天演药业有限公司（以下简称为“天演药业”）（纳斯达克股票代码：ADAG）是一家平台驱动型临床阶段生物制药公司，致力于改变新型抗体免疫疗法的发现和开发。该公司今天宣布，其将被添加到富时全球股权指数体系（以下简称为“GEIS”），包括富时全球总市值指数和富时新兴全盘指数，并将于6月21日生效。 FTSE...
Adagene Announces Inclusion in FTSE Russell Indexes
June 16, 2021 07:45 ET
|
Adagene Inc.
SAN FRANCISCO and SUZHOU, China, June 16, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the...
天演药业宣布2021年6月将出席多个投资者会议
May 25, 2021 16:05 ET
|
Adagene Inc.
中国苏州和美国旧金山, May 26, 2021 (GLOBE NEWSWIRE) --...
Adagene to Present at Upcoming Investor Conferences
May 25, 2021 16:05 ET
|
Adagene Inc.
SAN FRANCISCO, Calif. and SUZHOU, China, May 25, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to...
天演药业将在2021年ASCO年会上公布ADG106最新临床成果
May 19, 2021 20:00 ET
|
Adagene Inc.
-筛选到与临床疗效和靶点结合相关的预测性生物标志物与药效生物标志物- -ADG106单一疗法安全性良好- 中国苏州和美国旧金山, May 20, 2021 (GLOBE NEWSWIRE) --...